Industry Digs Into Specifics Of CMS Proposal For Covering Clinical Trial Costs
This article was originally published in The Gray Sheet
Executive Summary
Device industry representatives say CMS' latest proposed revision of its policy for covering certain clinical trial costs is a significant improvement over the previous proposal, but claim some specific requirements would be too burdensome on manufacturers
You may also be interested in...
CMS Maintains Status Quo On Clinical Trial Coverage, Again
Under intense pressure from Congress, industry and the medical research community, CMS has decided to maintain the status quo for coverage of routine costs in clinical trials
CMS Maintains Status Quo On Clinical Trial Coverage, Again
Under intense pressure from Congress, industry and the medical research community, CMS has decided to maintain the status quo for coverage of routine costs in clinical trials
Medicare In Brief
MedCAC priority list: The Medicare Evidence Development and Coverage Advisory Committee will convene Oct. 22 to develop a list of priority research topics with the most potential impact on the Medicare program and its beneficiaries. The list will be a framework for the scientific community to advance evidence development, CMS says...